| Literature DB >> 35049971 |
Micael F M Gonçalves1, Sandra Hilário1, Yves Van de Peer2,3,4,5, Ana C Esteves1, Artur Alves1.
Abstract
The genus Emericellopsis is found in terrestrial, but mainly in marine, environments with a worldwide distribution. Although Emericellopsis has been recognized as an important source of bioactive compounds, the range of metabolites expressed by the species of this genus, as well as the genes involved in their production are still poorly known. Untargeted metabolomics, using UPLC- QToF-MS/MS, and genome sequencing (Illumina HiSeq) was performed to unlock E. cladophorae MUM 19.33 chemical diversity. The genome of E. cladophorae is 26.9 Mb and encodes 8572 genes. A large set of genes encoding carbohydrate-active enzymes (CAZymes), secreted proteins, transporters, and secondary metabolite biosynthetic gene clusters were identified. Our analysis also revealed genomic signatures that may reflect a certain fungal adaptability to the marine environment, such as genes encoding for (1) the high-osmolarity glycerol pathway; (2) osmolytes' biosynthetic processes; (3) ion transport systems, and (4) CAZymes classes allowing the utilization of marine polysaccharides. The fungal crude extract library constructed revealed a promising source of antifungal (e.g., 9,12,13-Trihydroxyoctadec-10-enoic acid, hymeglusin), antibacterial (e.g., NovobiocinA), anticancer (e.g., daunomycinone, isoreserpin, flavopiridol), and anti-inflammatory (e.g., 2'-O-Galloylhyperin) metabolites. We also detected unknown compounds with no structural match in the databases used. The metabolites' profiles of E. cladophorae MUM 19.33 fermentations were salt dependent. The results of this study contribute to unravel aspects of the biology and ecology of this marine fungus. The genome and metabolome data are relevant for future biotechnological exploitation of the species.Entities:
Keywords: anticancer; antimicrobial; marine fungi; metabolites; whole genome sequencing
Year: 2021 PMID: 35049971 PMCID: PMC8780691 DOI: 10.3390/jof8010031
Source DB: PubMed Journal: J Fungi (Basel) ISSN: 2309-608X
General statistics of the Emericellopsis cladophorae MUM 19.33 genome assembly, and gene prediction.
| General Features | |
|---|---|
| Genome assembled | 26.9 Mb |
| Number of contigs (>500 bp) | 300 |
| Largest contig length | 1,489,480 bp |
| N50 | 315,653 bp |
| N75 | 183,754 bp |
| GC content | 54.34% |
| Number of predicted genes | 8572 |
| Total length of predicted genes | 13,253,623 bp |
| Average length of predicted genes | 1546 bp |
| Total length of predicted genes/Genome assembled | 49.2% |
| Average of exons per gene | 3 |
| Average of introns per gene | 2 |
Statistical results of repetitive sequences and noncoding RNAs for the Emericellopsis cladophorae MUM 19.33 genome. SINEs: short interspersed nuclear elements; LINEs: long interspersed nuclear elements; LTRs: long terminal repeats.
| Type | Number | Total Length (bp) | Percentage in Genome (%) | |
|---|---|---|---|---|
| Interspersed repeat | SINEs | 0 | 0 | 0.0000 |
| LINEs | 3 | 196 | 0.0007 | |
| LTRs | 128 | 48,958 | 0.1817 | |
| DNA transposons | 22 | 1362 | 0.0051 | |
| Rolling-circles | 1 | 37 | 0.0001 | |
| Unclassified | 0 | 0 | 0.0000 | |
| Small RNA | 62 | 9505 | 0.0353 | |
| Satellites | 5 | 698 | 0.0026 | |
| Simple repeats | 4656 | 183,030 | 0.6794 | |
| Low complexity | 381 | 17,309 | 0.0643 | |
| Total | 5258 | 261,095 | 0.9692 | |
| Tandem repeat | 2365 | 232,036 | 0.8614 |
Figure 1Gene Ontology (GO) functional annotation (pie charts) and EggNOG functional classification (bars charts) of Emericellopsis cladophorae MUM 19.33 genome.
Genes predicted to code for transporters in the genome of Emericellopsis cladophorae MUM 19.33.
| Transporter Class | Number of Genes (n) |
|---|---|
| Channels and pores (TC 1) | 461 |
| Electrochemical potential-driven transporters (TC 2) | 570 |
| Primary active transporters (TC 3) | 405 |
| Group translocators (TC 4) | 77 |
| Transmembrane electron carriers (TC 5) | 30 |
| Accessory factors involved in transport (TC 8) | 270 |
| Incompletely characterized transport systems (TC 9) | 384 |
| Total | 2197 |
Figure 2Comparison of three biosynthetic gene regions in Emericellopsis cladophorae MUM 19.33 with (A) Ascochlorin BGC of Acremonium egyptiacum F-1392; (B) Cephalosporin C BGC of Acremonium chrysogenum ATCC 11,550; and (C) Leucinostatin A/B BGC of Purpureocillium lilacinum PLBJ-1. The genes that encode hypothetical proteins are represented as white arrows.
Figure 3Model illustrating the high-osmolarity glycerol (HOG)—mitogen-activated protein kinase (MAPK) pathway in Emericellopsis cladophorae MUM 19.33, based on the Saccharomyces cerevisiae HOG-MAPK pathway. Genes that were detected are highlighted in blue. Arrows indicate possible connections. The figure was created with BioRender.com (accessed on 23 September 2021).
Overview of genome assembly and gene statistics for Emericellopsis cladophorae MUM 19.33 and E. atlantica TS7. AA: auxiliary activity; CBM: carbohydrate binding modules; CE: carbohydrate esterases; GH: glycoside hydrolases; GT glycosyltransferases; PL: polysaccharide lyases; NRPS: non-ribosomal peptide synthases; PKs: polyketide synthases.
| Genome assembled | 26.9 Mb | 27.3 Mb | |
| Coverage | 130 | 225.6 | |
| GC content | 54.34% | 54.2% | |
| Number of genes | 8572 | 9964 | |
| Average genes length | 1546 bp | 1832 bp | |
| Genes encoding CAZymes | 407 | 396 | |
| AA | 72 | 53 | |
| CBM | 8 | 40 | |
| CE | 28 | 21 | |
| GH | 200 | 217 | |
| GT | 83 | 93 | |
| PL | 16 | 17 | |
| BGCs | 37 | 35 | |
| NRPS | 10 | 8 | |
| NRPS-like | 7 | 6 | |
| PKs | 6 | 6 | |
| NRPS-PKs | 5 | 3 | |
| NRPS-like-PKs | 1 | 0 | |
| NRPS-PKs-hybrid | 0 | 1 | |
| Terpenes | 7 | 9 | |
| Indole | 0 | 1 | |
| Phosphonate | 1 | 1 |
Figure 4Principal Component Analysis (PCA) scores plot of salted and non-salted extracts of Emericellopsis cladophorae MUM 19.33. Green represents salted extracts and in red non-salted extracts.
Figure 5Structural classification of up and down regulated (p < 0.01) metabolites produced by Emericellopsis cladophorae MUM 19.33, grown in the presence of sea salts.
Metabolites with biotechnological potential of Emericellopsis cladophorae MUM 19.33 belonging to various chemical classes and related functions. Metabolites were annotated at MSI-level 2. m/z—ration mass/charge; Rt—retention time (min).
| Putative Metabolite | Rt | Adduct | Molecular Formula | Class | Function | |
|---|---|---|---|---|---|---|
| (-)-Gallocatechin 3-gallate | 169.0130 | 6.87 | [M−H-C15H12O6]− | C22H18O11 | Benzopyrans | Antioxidant activity and inhibitory ability on α-amylase and α-glucosidase related to diabetes mellitus [ |
| (-)-Riboflavin | 375.1300 | 8.16 | [M−H]− | C17H20N4O6 | Vitamin | Known as vitamin B2 and is the central source of all important flavins [ |
| 2’-O-Galloylhyperin | 307.0484 | 10.47 | [M−2H]− | C28H24O16 | Carboxilic Acid | Antioxidant and anti-inflammatory [ |
| 3-Isomangostin | 427.1782 | 4.91 | [M + OH]− | C24H26O6 | Xanthone | Derivative of mangostin that has antioxidant, anti-inflammatory, anticancer and anti-microbial activities [ |
| 3,4-dihydroxycinnamic acid | 264.0863 | 17.01 | [M−H]− | C13H15NO5 | Carboxylic Acid | Antioxidant, anti-cancer, anti-viral and anti- inflammatory [ |
| 9,12,13-Trihydroxyoctadec-10-enoic acid | 329.2324 | 23.40 | [M−H]− | C18H34O5 | Carboxilic Acid | Antifungal [ |
| Citric Acid | 191.0185 | 1.56 | [M−H]− | C6H8O7 | Carboxylic Acid | Antioxidant, preservative, acidulant and pH- regulator [ |
| Daidzein | 253.0498 | 14.82 | [M−H]− | C15H10O4 | Flavonoids | Anticancer, anti-inflammatory, protective effects against osteoporosis, diabetes, and cardiovascular diseases [ |
| Daunomycinone | 379.0825 | 1.05 | [M−H-H2O]− | C21H18O8 | Naphthacene | Antibiotic with anti-cancer activity [ |
| (-)-Epigallocatechin | 611.1352 | 2.55 | [2M−H]− | C15H14O7 | Benzopyrans | Antiviral, antimicrobial, antitoxin and anticancer [ |
| Ergocryptine | 558.0951 | 16.35 | [M−H]− | C32H41N5O5 | Alkaloids | Cause ergot in cereal grains and fescue toxicoses in animals [ |
| Flavopiridol | 382.0995 | 3.92 | [M−H]− | C21H20ClNO5 | Piperidines | Treatment of chronic lymphocytic leukemia [ |
| Guanosine | 282.0838 | 2.27 | [M−H]− | C10H13N5O5 | Nucleosides | Antioxidant, neuroprotective, cardiotonic and immuno-modulatory properties [ |
| Hymeglusin | 647.3769 | 21.57 | [2M−H]− | C18H28O5 | Lactones | Fungal beta-lactone antibiotic with anti-fungal activity [ |
| Isoreserpin | 607.2677 | 2.33 | [M−H]− | C33H40N2O9 | Alkaloids | Anticancer [ |
| Laminaritetraose | 701.1903 | 1.10 | [M + Cl]− | C24H42O21 | Carbohydrates | Obtained from hydrolysis of laminarin, which is a carbohydrate food reserve [ |
| N4-Acetylsulfadiazine | 291.0537 | 15.90 | [M−H]− | C12H12N4O3S | Sulfonamide | Marine xenobiotic which is the main constituent of sulfadiazine (antibiotic) [ |
| NovobiocinA | 611.2305 | 4.49 | [M−H]− | C31H36N2O11 | Glycoside | Antibacterial [ |
| Palatinose | 341.1078 | 1.05 | [M−H]− | C12H22O11 | Carbohydrates | Obtained from the enzymatic conversion of sucrose, used in food industries as a sugar substitute [ |
| Pantothenic acid | 18.1024 | 3.84 | [M−H]− | C9H17NO5 | Vitamin | Known as vitamin B5 and is essential for fatty acid and carbohydrate metabolism. It may be an attractive target for antifungal therapy [ |
| Phosphatidylethanolamine | 612.3720 | 7.33 | [M−H]− | C32H56NO8P | Glycerophospholipids | Antifungal [ |
| Porphobilinogen | 225.0870 | 3.72 | [M−H]− | C10H14N2O4 | Pirrole | Involved in the heme biosynthetic pathway and protection from nitrosative stress [ |
| Salicylic acid | 137.0237 | 4.12 | [M−H]− | C7H6O3 | Carboxilic Acid | Antifungal [ |